Leah Albrecht
Women's Health · Gillette, WYNPI 1104366806
Payments from drug & device makers
Across 102 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$847
- Biohaven Pharmaceutical Holding Company Ltd.$160
- Amgen$158
- Novo Nordisk$118
- Biohaven Pharmaceuticals, Inc.$75
- Pfizer$73
- plus $586 from 17 others
What the payments were for
- Food & beverage$2,00299%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $847 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $160 |
| Amgen | 10 | $158 |
| Novo Nordisk | 6 | $118 |
| Biohaven Pharmaceuticals, Inc. | 3 | $75 |
| Pfizer | 4 | $73 |
| Lilly USA, LLC | 4 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Daiichi Sankyo Inc. | 3 | $52 |
| Hologic Sales And Service, LLC | 2 | $50 |
| Organon | 6 | $50 |
| Astellas Pharma US Inc | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Pharmacosmos Therapeutics Inc. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Shield Therapeutics Inc | 1 | $27 |
| Baxter Healthcare | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Vertex | 1 | $22 |
| Merck | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Eisai Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
How this compares
Too few women's health providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 25 | $1,471 |
| Estradiol | 23 | $1,367 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 11 | $327 |
| Levothyroxine Sodium | 35 | $289 |
| Duloxetine Hcl | 11 | $285 |
| Alprazolam | 32 | $154 |
| Lisinopril | 19 | $93 |
| Fluconazole | 18 | $88 |
| Hydrochlorothiazide | 24 | $75 |
| Losartan Potassium | 26 | $75 |
| Simvastatin | 15 | $67 |
| Cyclobenzaprine Hcl | 15 | $15 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $11 |
| Tramadol Hcl | 12 | $0 |
Paid to pharmacies, not to this prescriber.
Other women's health in Gillette
- Brittany QuinnAlpine$220
- Kelly GebauerCheyenne$148
- Becky OlsonSheridan$147
- Rauli PerryPinedale$112
- Monica GonzalesCasper$21
- Jacqueline RetherfordDouglas$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.